NEUROCRINE BIOSCIENCES INC COM is a security (CUSIP 64125C109) tracked across SEC portfolio filings. 782 institutional managers reported $13.3B on Form 13F as of 2026-06-30; 61 registered fund positions totaling $899.1M via N-PORT as of 2026-06-30.
Showing 15 of 782 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| BlackRock, Inc. | New York, NY | $1.8B | 13,385,607 |
| VANGUARD GROUP INC | Valley Forge, PA | $1.4B | 9,700,301 |
| Dodge & Cox | San Francisco, CA | $719.4M | 5,461,037 |
| JPMORGAN CHASE & CO | NEW YORK, NY | $700.5M | 5,442,067 |
| AQR CAPITAL MANAGEMENT LLC | Greenwich, CT | $650.7M | 4,938,967 |
| STATE STREET CORP | BOSTON, MA | $573.7M | 4,354,526 |
| TWO SIGMA INVESTMENTS, LP | New York, NY | $403.2M | 3,060,570 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $318.7M | 2,418,897 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $280.8M | 2,136,672 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Paris, I0 | $196.8M | 1,493,813 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $183.1M | 1,389,539 |
| Vestal Point Capital, LP | NEW YORK, NY | $164.7M | 1,250,000 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $164.3M | 1,247,447 |
| NORTHERN TRUST CORP | CHICAGO, IL | $163.7M | 1,242,830 |
| UBS Group AG | Zurich, V8 | $160.9M | 1,221,036 |
Showing 15 of 61 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| State Street SPDR S&P MidCap 400SM ETF Trust | SPDR S&P MIDCAP 400 ETF TRUST | $398.6M | 164.60% |
| JPMorgan Growth Advantage Fund | J.P. Morgan Mutual Fund Investment Trust | $174.3M | 86.39% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $59.8M | 27.49% |
| VANGUARD CAPITAL OPPORTUNITY FUND | VANGUARD HORIZON FUNDS | $55.0M | 22.33% |
| VANGUARD HEALTH CARE INDEX FUND | VANGUARD WORLD FUND | $47.4M | 24.95% |
| AB DISCOVERY GROWTH FUND, INC. | AB DISCOVERY GROWTH FUND, INC. | $28.1M | 104.19% |
| Fidelity Series Total Market Index Fund | Fidelity Concord Street Trust | $24.2M | 2.17% |
| VANGUARD S&P MID-CAP 400 GROWTH INDEX FUND | VANGUARD ADMIRAL FUNDS | $15.9M | 87.03% |
| Eaton Vance Tax-Advantaged Dividend Income Fund | Eaton Vance Tax-Advantaged Dividend Income Fund | $12.2M | 57.24% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $10.5M | 103.70% |
| Schwab U.S. Broad Market ETF | SCHWAB STRATEGIC TRUST | $9.4M | 2.17% |
| Large Cap Index Master Portfolio | Master Investment Portfolio | $7.8M | 2.14% |
| PRIMECAP Odyssey Growth Fund | PRIMECAP Odyssey Funds | $7.3M | 13.45% |
| BlackRock Mid-Cap Value Fund | BlackRock Mid-Cap Value Series, Inc. | $5.6M | 52.91% |
| BNY Mellon Midcap Index Fund, Inc. | BNY MELLON MIDCAP INDEX FUND, INC. | $5.3M | 38.33% |